Will osteopontin bridge the gap towards clinical application in chronic kidney disease?-Reference-Cited by-同舟云学术

Will osteopontin bridge the gap towards clinical application in chronic kidney disease?

Published:2023-03-20 Issue:6 Volume:38 Page:1352-1354
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

de Borst Martin H¹^ORCID,Carrero Juan-Jesus²³

Affiliation:

1. Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen , Groningen , The Netherlands

2. Department of Medical Epidemiology and Biostatistics, Karolinska Institute , Stockholm , Sweden

3. Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet , Danderyd Hospital, Stockholm , Sweden

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfad057/50362461/gfad057.pdf

Reference13 articles.

1. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD Chronic Kidney Disease Collaboration;Lancet North Am Ed,2020

2. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories;Foreman;Lancet North Am Ed,2018

3. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study;Steinbrenner;Nephrol Dial Transplant,2022

4. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease;Scatena;ATVB,2007

5. Osteopontin function in pathology: lessons from osteopontin-deficient mice;Rittling;Nephron Exp Nephrol,1999